13F filer · CIK 1418329 ↗

Ninety One UK Ltd

You are looking at Q2 2016. See the latest, Q3 2026 →

Reported value

$19.33B

+4.5% on the quarter before

Positions

291

29 new · 41 sold out

Top 10

19.0%

of the value

Est. gain

+$55.1M

on stocks held all quarter

Est. return

+0.3%

on those stocks since Q1 2016

Filed

Aug 12, 2016

On SEC EDGAR ↗

Positions as of Jun 30, 2016, from Ninety One UK Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

New
Added
Cut
Same
Options

The 24 largest positions, 37% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.

Johnson & Johnson3.1%

Citigroup Inc2.3%

Unitedhealth Group Inc2.0%

AT&T1.8%

Pepsico Inc1.7%

Activision Blizzard Inc1.7%

Microsoft1.6%

Priceline Group Inc/The1.6%

Cisco1.5%

Philip Morris International In1.5%

Honeywell Technologies1.5%PayPal1.5%

Comcast Corp1.5%

Pfizer Inc1.4%

Alphabet1.3%

Gilead Sciences Inc1.3%

Zimmer Holdings Inc1.3%

Check Point Software Technolog1.2%

Valero Energy Corp1.2%

Vantiv Inc1.2%

Aflac Inc1.2%

Visa Inc.1.2%

Nxp Semiconductor Nv1.1%

Medtronic Plc1.1%

Johnson & Johnson3.1%

Citigroup Inc2.3%

Unitedhealth Group Inc2.0%

AT&T1.8%

Pepsico Inc1.7%

Activision Blizzard Inc1.7%

Microsoft1.6%

Priceline Group Inc/The1.6%

Cisco1.5%

Philip Morris International In1.5%

Honeywell Technologies1.5%PayPal1.5%

Comcast Corp1.5%

Pfizer Inc1.4%

Alphabet1.3%

Gilead Sciences Inc1.3%

Zimmer Holdings Inc1.3%

Check Point Software Technolog1.2%

Valero Energy Corp1.2%

Vantiv Inc1.2%

Aflac Inc1.2%

Visa Inc.1.2%

Nxp Semiconductor Nv1.1%

Medtronic Plc1.1%

Largest buys

Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Alibaba~$213.2MNew · 0.0% → 1.1%+2,681,164 shares
Johnson Controls Inc~$209.9MNew · 0.0% → 1.1%+4,935,228 shares
Bank Of New York Mellon Corp~$166.4MAdded · 0.1% → 1.0%+4,492,674 shares
Carnival Corp~$120.5MAdded · 0.1% → 0.7%+2,726,935 shares
Aflac Inc~$100.2MAdded · 0.6% → 1.2%+1,445,793 shares
Signet Jewelers Ltd~$76.3MAdded · 0.1% → 0.4%+925,860 shares
Unitedhealth Group Inc~$68.7MAdded · 1.6% → 2.0%+497,175 shares
New Oriental Education & Techn~$67.4MNew · 0.0% → 0.3%+1,609,176 shares
Marriott Vacations Worldwide C~$64.8MNew · 0.0% → 0.3%+1,058,614 shares
Michael Kors Holdings Ltd~$59.6MNew · 0.0% → 0.3%+1,204,562 shares

Largest sells

Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Amercian Int'L Group Inc~$211.6MSold out · 1.1% → 0.0%−3,915,365 shares
Netease Inc~$140.1MCut · 1.0% → 0.6%−725,088 shares
Synaptics~$77.7MSold out · 0.4% → 0.0%−974,629 shares
Thor Industries Inc~$67.6MCut · 0.6% → 0.3%−1,043,879 shares
Foot Locker Inc~$64.7MSold out · 0.3% → 0.0%−1,002,601 shares
Emc Corp/Ma~$55.3MCut · 0.9% → 0.6%−2,036,559 shares
Voya Financial Inc~$52.4MCut · 0.9% → 0.4%−2,116,880 shares
Cardinal Health Inc~$51.4MCut · 0.6% → 0.2%−695,130 shares
Synnex Corp~$48.9MSold out · 0.3% → 0.0%−528,559 shares
Chevron Corp~$35.4MCut · 0.3% → 0.1%−337,417 shares

Holdings

As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
#	Holding		% prev	Value	Shares		Price	Prev price
1	Johnson & JohnsonCommon Stock · shares +1.2% · price +9.9%	3.1%	3.0%	$607.3M	5.1M	+1.2%	$118.87	$108.20	+9.9%	+$53.9M
2	Citigroup IncCommon Stock · shares +1.8% · price −0.2%	2.3%	2.4%	$451.8M	10.8M	+1.8%	$41.65	$41.75	−0.2%	−$1.0M
3	Unitedhealth Group IncCommon Stock · shares +21% · price +7.1%	2.0%	1.6%	$394.1M	2.9M	+21%	$138.09	$128.90	+7.1%	+$21.7M
4	AT&TCommon Stock · shares −3.0% · price +6.7%	1.8%	1.8%	$345.1M	8.3M	−3.0%	$41.81	$39.17	+6.7%	+$21.8M
5	Pepsico IncCommon Stock · shares +0.8% · price +3.4%	1.7%	1.7%	$337.0M	3.2M	+0.8%	$105.94	$102.48	+3.4%	+$10.9M
6	Activision Blizzard IncCommon Stock · shares −8.0% · price +12.9%	1.7%	1.7%	$322.0M	8.4M	−8.0%	$38.20	$33.84	+12.9%	+$36.7M
7	MicrosoftCommon Stock · shares +1.0% · price −7.4%	1.6%	1.8%	$312.8M	6.1M	+1.0%	$51.17	$55.23	−7.4%	−$24.6M
8	Priceline Group Inc/TheCommon Stock · shares +21% · price −6.2%	1.6%	1.5%	$312.7M	258,543	+21%	$1,209.34	$1,288.96	−6.2%	−$17.1M
9	CiscoCommon Stock · shares −0.7% · price −2.8%	1.5%	1.7%	$297.6M	10.7M	−0.7%	$27.68	$28.47	−2.8%	−$8.5M
10	Philip Morris International InCommon Stock · shares −4.2% · price −0.4%	1.5%	1.7%	$297.4M	3.0M	−4.2%	$97.67	$98.11	−0.4%	−$1.3M
11	Honeywell TechnologiesCommon Stock · shares +25% · price +0.5%	1.5%	1.3%	$291.0M	2.6M	+25%	$112.55	$112.05	+0.5%	+$1.0M
12	PayPalCommon Stock · shares −0.5% · price −8.7%	1.5%	1.7%	$289.9M	8.2M	−0.5%	$35.26	$38.60	−8.7%	−$27.5M
13	Comcast CorpCommon Stock · shares −3.7% · price +2.6%	1.5%	1.5%	$280.7M	4.5M	−3.7%	$62.65	$61.08	+2.6%	+$7.0M
14	Pfizer IncCommon Stock · shares −0.4% · price +18.8%	1.4%	1.2%	$262.6M	7.5M	−0.4%	$35.21	$29.64	+18.8%	+$41.5M
15	AlphabetCommon Stock · shares +17% · price −11.0%	1.3%	1.3%	$259.0M	381,515	+17%	$678.89	$762.90	−11.0%	−$27.5M
16	Gilead Sciences IncCommon Stock · shares +4.3% · price −12.0%	1.3%	1.5%	$257.3M	3.2M	+4.3%	$80.86	$91.86	−12.0%	−$33.6M
17	Zimmer Holdings IncCommon Stock · shares −4.9% · price +12.9%	1.3%	1.3%	$254.2M	2.1M	−4.9%	$120.38	$106.63	+12.9%	+$29.0M
18	Check Point Software TechnologCommon Stock · shares +13% · price −12.6%	1.2%	1.3%	$240.2M	3.1M	+13%	$76.46	$87.47	−12.6%	−$30.7M
19	Valero Energy CorpCommon Stock · shares +11% · price −23.1%	1.2%	1.5%	$239.8M	4.9M	+11%	$49.30	$64.14	−23.1%	−$64.9M
20	Vantiv IncCommon Stock · shares −6.0% · price +0.8%	1.2%	1.3%	$232.4M	4.3M	−6.0%	$54.29	$53.88	+0.8%	+$1.8M
21	Aflac IncCommon Stock · shares +77% · price +9.7%	1.2%	0.64%	$230.7M	3.3M	+77%	$69.29	$63.14	+9.7%	+$11.6M
22	Visa Inc.Common Stock · shares +12% · price −3.0%	1.2%	1.1%	$225.1M	3.0M	+12%	$74.17	$76.48	−3.0%	−$6.2M
23	Nxp Semiconductor NvCommon Stock · shares −5.6% · price −3.4%	1.1%	1.3%	$217.9M	2.8M	−5.6%	$78.34	$81.07	−3.4%	−$7.6M
24	Medtronic PlcCommon Stock · shares −4.5% · price +9.8%	1.1%	1.1%	$215.0M	2.6M	−4.5%	$82.32	$75.00	+9.8%	+$19.1M
25	AlibabaADR · shares New	1.1%	—	$213.2M	2.7M	New	$79.53	—	—	—
	Total · 291 positions	100%		$19.33B						+$55.1M

The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2016 to Q2 2016: 262 stocks held throughout, up $55.1M (+0.3%).

Johnson & Johnson+$53.9M+10%
Pfizer Inc+$41.5M+19%
Activision Blizzard Inc+$36.7M+13%
Newmont Mining Corp+$32.4M+47%
Netease Inc+$30.9M+35%
Alphabet−$27.5M−11%
Check Point Software Technolog−$30.7M−13%
Baidu−$31.9M−13%
Gilead Sciences Inc−$33.6M−12%
Valero Energy Corp−$64.9M−23%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$100.00B$50.00B$0

Q1 201643 quartersQ3 2026

Every quarter's filing

Each quarter's 13F filing, newest first
Quarter	Filed	Reported value	Positions	Filing
Q3 2026	Oct 15, 2026	$45.47B+2%	331	SEC ↗
Q2 2026	Jul 16, 2026	$44.73B+4%	271	SEC ↗
Q1 2026	Apr 24, 2026	$43.13B−8%	237	SEC ↗
Q4 2025	Jan 27, 2026	$46.64B−49%	225	SEC ↗
Q3 2025	Oct 21, 2025 (amended)	$91.76B+115%	210	SEC ↗
Q2 2025	Jul 18, 2025	$42.61B+19%	202	SEC ↗
Q1 2025	Apr 30, 2025	$35.94B−4%	193	SEC ↗
Q4 2024	Jan 27, 2025	$37.38B−0%	191	SEC ↗
Q3 2024	Nov 12, 2024	$37.47B+3%	194	SEC ↗
Q2 2024	Jul 22, 2024	$36.22B+2%	187	SEC ↗
Q1 2024	Apr 25, 2024	$35.61B+6%	185	SEC ↗
Q4 2023	Jan 31, 2024	$33.61B+6%	178	SEC ↗
Q3 2023	Oct 10, 2023	$31.62B−8%	177	SEC ↗
Q2 2023	Jul 19, 2023	$34.27B+7%	183	SEC ↗
Q1 2023	Apr 28, 2023	$32.10B+3%	180	SEC ↗
Q4 2022	Feb 7, 2023	$31.19B+3%	187	SEC ↗
Q3 2022	Nov 14, 2022	$30.32B−10%	190	SEC ↗
Q2 2022	Aug 15, 2022	$33.63B−14%	190	SEC ↗
Q1 2022	May 26, 2022	$39.26B−7%	196	SEC ↗
Q4 2021	Feb 11, 2022	$42.13B+8%	208	SEC ↗
Q3 2021	Nov 2, 2021	$39.16B+1%	208	SEC ↗
Q2 2021	Aug 12, 2021	$38.59B+10%	209	SEC ↗
Q1 2021	May 7, 2021	$35.18B+8%	215	SEC ↗
Q4 2020	Feb 5, 2021	$32.51B+18%	219	SEC ↗
Q3 2020	Nov 12, 2020	$27.65B−2%	223	SEC ↗
Q2 2020	Sep 4, 2020 (amended)	$28.22B+19%	233	SEC ↗
Q1 2020	May 12, 2020	$23.77B−21%	232	SEC ↗
Q4 2019	Feb 7, 2020	$30.15B+17%	238	SEC ↗
Q3 2019	Nov 14, 2019	$25.69B−2%	235	SEC ↗
Q2 2019	Jul 30, 2019	$26.28B+4%	265	SEC ↗
Q1 2019	Apr 24, 2019	$25.24B+9%	271	SEC ↗
Q4 2018	Feb 8, 2019	$23.19B−13%	283	SEC ↗
Q3 2018	Nov 13, 2018	$26.80B+33%	274	SEC ↗
Q2 2018	Aug 10, 2018	$20.13B+8%	259	SEC ↗
Q1 2018	May 14, 2018	$18.67B−23%	238	SEC ↗
Q4 2017	Feb 13, 2018	$24.34B+7%	306	SEC ↗
Q3 2017	Nov 13, 2017	$22.78B+8%	308	SEC ↗
Q2 2017	Aug 11, 2017	$21.00B+4%	311	SEC ↗
Q1 2017	May 12, 2017	$20.25B+6%	308	SEC ↗
Q4 2016	Feb 10, 2017	$19.15B−7%	305	SEC ↗
Q3 2016	Nov 14, 2016	$20.53B+6%	300	SEC ↗
Q2 2016	Aug 12, 2016	$19.33B+5%	291	SEC ↗
Q1 2016	May 12, 2016	$18.49B	303	SEC ↗